Scribe Therapeutics

SCTXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$420.732 M

$26.00 +2.32%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#74X4 PharmaceuticalsXFOR$437.6M
#75OcugenOCGN$434.1M
#76Scribe TherapeuticsSCTX$420.7M
#77Sutro BiopharmaSTRO$420.6M
#78C4 TherapeuticsCCCC$412.4M

Where these numbers come from

Share counts and financials for Scribe Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.